Home » Labopharm Gets FDA Approval for Once-a-Day Oleptro
Labopharm Gets FDA Approval for Once-a-Day Oleptro
Labopharm Inc. said Wednesday it received marketing approval for its antidepressant
Oleptro, a once-per-day version of a depression drug that is usually given twice a day.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May